Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Biobehavioral Bases & Management of Type 2 Diabetes
Brief Summary: The major objective of this project is to determine if compared to Standard Care (SC), a Community Approach to Lifestyle Modification for Diabetes (CALM-D) program including diet, exercise and coping skills training, can decrease depression, weight and HbA1c and improve medication adherence in low income, primarily Black and Latino/Hispanic, depressed, overweight, Type 2 diabetic patients seen in a large, comprehensive, community health center. Type 2 diabetes is a major risk factor for coronary heart disease (CHD). Obesity, poor glycemic control, depression, low socioeconomic status (SES) and being a member of a racial/ethnic minority group all increase this risk.

The project will compare 100 CALM-D and 100 SC participants. Following 3 run-in sessions assessment sessions to determine eligibility, given to both SC and CALM-D participants, SC patients will be treated in accordance with ADA Clinical Practice Guidelines (2005) and also assessed by project staff at baseline, 6 months and 1 year. The CALM-D participants will receive 2 individual stress management and lifestyle sessions followed by 2 weekly group sessions. Then 4 bi-weekly sessions will be followed by 9 monthly sessions for a total of 17 sessions. Secondary objectives of the project are to determine if compared to SC, CALM-D can improve glucose tolerance to challenge, insulin resistance, oxidative stress, inflammation, procoagulation, lipid profile, endothelial function resting blood pressure, cardiac and vascular function, cardiac morphology, psychosocial functioning and health quality of life. As many of the participants will already have been prescribed aspirin, statins, oral hypoglycemics and other medications, an important objective of the project will be to assess the extent to which improved adherence to medications - a goal of the CALM-D program - can account for improved intervention effects.


Options:
A: Arm Label: Virtual MBCT Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Adapted MBCT | Arm Label: Virtual Health Enhancement Control; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Health Enhancement | Intervention Type: BEHAVIORAL; Name: Adapted MBCT; Assigned to Arm(s): Virtual MBCT Intervention | Intervention Type: BEHAVIORAL; Name: Cardiac Health Enhancement; Assigned to Arm(s): Virtual Health Enhancement Control
B: Arm Label: real-time, face-to-face, video-conferenced CBT (vcCBT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Online cognitive behavioral therapy | Arm Label: self-administered internet-based CBT (iCBT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Online cognitive behavioral therapy | Intervention Type: BEHAVIORAL; Name: Online cognitive behavioral therapy; Assigned to Arm(s): real-time, face-to-face, video-conferenced CBT (vcCBT), self-administered internet-based CBT (iCBT)
C: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: CALM-D Intervention | Intervention Type: BEHAVIORAL; Name: CALM-D Intervention; Assigned to Arm(s): Lifestyle counseling
D: Arm Label: Clinical Management; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CBT + WBT; Type: EXPERIMENTAL; Interventions: Behavioral: CBT in combination with WBT and life style modification | Intervention Type: BEHAVIORAL; Name: CBT in combination with WBT and life style modification; Assigned to Arm(s): CBT + WBT

Answer: C